About RIBOHOLDING ApS
RIBOHOLDING ApS is a Private Limited Company and was incorporated on Dec 31, 2005 in Denmark. Its corporate identification number is (CIN) 29835772 and its current status is Active.
Key Metrics
CIN
29835772
Current Status
Active
Entity Type
Private Limited Company
Date Of Incorporation
Dec 31, 2005
Brands associated with RIBOHOLDING ApS
There is one brand associated with RIBOHOLDING ApS which include RiboTask .
Financials of RIBOHOLDING ApS
Competitors & Alternates of RIBOHOLDING ApS
RiboTask is the only brand associated with RIBOHOLDING ApS, and here are its Top 10 competitors ranked by Tracxn score:
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Orna 2020, Cambridge (United States), Acquired | Developer of technologies for producing circular RNA therapeutics | $201M | 66/100 | |
2nd | Enzo 1976, Farmingdale (United States), Acquired | Life science products and services for research, drug discovery, and manufacturing | $7M | - | 65/100 |
3rd | Parse Biosciences 2018, Seattle (United States), Series C | Developer of RNA-sequencing solution-based transcriptome kit to analyze health data | $100M | 64/100 | |
4th | Sino Biological 2007, Beijing (China), Series A | Provider of reagents,and kits for clinical research | $29.4M | 63/100 | |
5th | Rznomics 2017, Yongin si (South Korea), Public | Developer of drugs for anti-cancer and refractory diseases based on RNA Platform technology | $48.7M | 62/100 | |
6th | OliX Pharmaceuticals 2010, Suwon-si (South Korea), Public | Developer of RNAi therapeutics for dermal, ophthalmic and pulmonary diseases. | - | 61/100 | |
7th | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | $15.5M | 61/100 | ||
8th | Dicerna Pharmaceuticals 2007, Lexington (United States), Acquired | Developer of drugs by using RNA interference technology platform | $106M | 60/100 | |
9th | Firefly BioWorks 2009, Cambridge (United States), Acquired | Develops platform to allow multiplexed assays on standard laboratory instrumentation | $3.77M | 59/100 | |
10th | Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised | Develops tools and products for research and clinical application | - | 58/100 | |
354th | Develops LNA-modified RNA oligonucleotides, RNAi and microRNA research applications; | - | 17/100 |
News related to RIBOHOLDING ApS
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Attribution:
Contains data used under the terms for the use of Danish public data
FAQs about RIBOHOLDING ApS
Explore our recently published Legal Entities
